Cost-benefit analysis of In Silico Resilience Trajectory Predictor

Summary
D72 aims at demonstrating the benefits to different stakeholders The results of the costbenefit analysis are crucial in justifying the adoption of the predictor in clinical practice
More information & hyperlinks
Web resources: https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5eb994810&appId=PPGMS
Search
Search on Google
Search on Bing
Search on DuckDuckGo
Associated projects
Organisations
  • Not specified
Powered by Chris Decubber BV